ING4 is also reportedly involved in the angiogenic switch in the progression of multiple myeloma and affects the production of the proangiogenic molecules IL-8 and osteopontin (OPN) by inhibiting hypoxia inducible factor-1 α (HIF-1α) under hypoxic conditions [48]. This evidence concerns the gene SPP1 and plasma cell myeloma.